These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19495517)

  • 1. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once daily dose gentamicin in neonates - is our dosing correct?
    Serane TV; Zengeya S; Penford G; Cooke J; Khanna G; McGregor-Colman E
    Acta Paediatr; 2009 Jul; 98(7):1100-5. PubMed ID: 19397541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels.
    Hansen A; Forbes P; Arnold A; O'Rourke E
    J Perinatol; 2003 Dec; 23(8):635-9. PubMed ID: 14647159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once daily gentamicin dosing in full term neonates.
    Alsaedi SA
    Saudi Med J; 2003 Sep; 24(9):978-81. PubMed ID: 12973482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants.
    Allegaert K; Debeer A; Cossey V; Rayyan M; Devlieger H
    Pediatr Crit Care Med; 2006 Mar; 7(2):143-6. PubMed ID: 16446602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin use in the neonatal intensive care unit: experience over 8 years.
    Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS
    Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime.
    Guadalupe Vásquez-Mendoza M; Vargas-Origel A; Del Carmen Ramos-Jiménez A; Aguilar-Orozco G; Romero-Gutiérrez G
    Am J Perinatol; 2007 Feb; 24(2):141-6. PubMed ID: 17304422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin alters auditory brainstem conduction time in newborns.
    Poblano A; Belmont A; Sosa J; Ibarra J; Vargas AM; Limón G; Martínez C
    J Perinat Med; 2003; 31(3):237-41. PubMed ID: 12825480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.
    Michaels LA; Gurian M; Hegyi T; Drachtman RA
    Pediatrics; 2004 Sep; 114(3):703-7. PubMed ID: 15342842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving perinatal regionalization by predicting neonatal intensive care requirements of preterm infants: an EPIPAGE-based cohort study.
    Vieux R; Fresson J; Hascoet JM; Blondel B; Truffert P; Roze JC; Matis J; Thiriez G; Arnaud C; Marpeau L; Kaminski M;
    Pediatrics; 2006 Jul; 118(1):84-90. PubMed ID: 16818552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prematurity on tear production.
    Akar Y; Cira A; Apaydin C; Erman MA; Yilmaz A
    Curr Eye Res; 2004 Feb; 28(2):145-51. PubMed ID: 14972720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates.
    Kiatchoosakun P; Kosalaraksa P; Jirapradittha J; Taksaphan S; Tassniyom S
    J Med Assoc Thai; 2005 Jul; 88(7):934-8. PubMed ID: 16241022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
    Moffett BS; Cannon BC; Friedman RA; Kertesz NJ
    Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.